Preoperative management of antiplatelet drugs for a coronary artery stent: how can we hit a moving target?

BACKGROUND: With the advent of percutaneous coronary intervention, specifically the bare metal stent and subsequently, the drug-eluting stent, the scope of interventional cardiology has greatly increased. Aspirin, in combination with a thienopyridine is the present-day cornerstone of oral antiplatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Thomas R, Hunter, James M, Boudreaux, Arthur M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151077/
https://www.ncbi.nlm.nih.gov/pubmed/25183953
http://dx.doi.org/10.1186/1471-2253-14-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151077/
https://www.ncbi.nlm.nih.gov/pubmed/25183953
http://dx.doi.org/10.1186/1471-2253-14-73

Ejemplares similares